The Biotechnology Company Is Involved In Psychedelic Drug Development

The Bright Minds biotechnology company has already been listed on the Canadian Stock Exchange and has been transformed into a publicly traded organization. There is a team of scientists & researchers who have brought extensive expertise and experience in drug discovery and development to develop first-generation psychedelic therapies.